Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Nature Communications
|
July 26, 2023
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
Guilherme Dias de Melo, Victoire Perraud, Flavio Alvarez, et al.
Plos Neglected Tropical Diseases
|
August 25, 2025
Dermal trypanosomes in seropositive suspects of gambiense human African trypanosomiasis in Côte d'Ivoire
Martial Kassi N'Djetchi, Mélika Barkissa Traoré, Innocent Abé, et al.
American Journal of Hematology
|
September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease
Abdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
The Journal of Clinical Investigation
|
February 7, 2020
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo
Yanqin Ren, Szu Han Huang, Shabnum Patel, et al.
Nature Communications
|
November 2, 2021
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Phanramphoei N Frantz, Aleksandr Barinov, Claude Ruffié, et al.
Ebiomedicine
|
July 17, 2022
Splenic clearance of rigid erythrocytes as an inherited mechanism for splenomegaly and natural resistance to malaria
Benoît Henry, Geoffroy Volle, Hilaire Akpovi, et al.
Open Forum Infectious Diseases
|
March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Nature Communications
|
January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
Nature Communications
|
May 14, 2021
Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
The Lancet. Infectious Diseases
|
February 15, 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial
Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Nature Communications
|
July 26, 2023
Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
Guilherme Dias de Melo, Victoire Perraud, Flavio Alvarez, et al.
Plos Neglected Tropical Diseases
|
August 25, 2025
Dermal trypanosomes in seropositive suspects of gambiense human African trypanosomiasis in Côte d'Ivoire
Martial Kassi N'Djetchi, Mélika Barkissa Traoré, Innocent Abé, et al.
American Journal of Hematology
|
September 17, 2024
Clearance of pathogenic erythrocytes is maintained despite spleen dysfunction in children with sickle cell disease
Abdoulaye Sissoko, Astan Cissé, Clémence Duverdier, et al.
The Journal of Clinical Investigation
|
February 7, 2020
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo
Yanqin Ren, Szu Han Huang, Shabnum Patel, et al.
Nature Communications
|
November 2, 2021
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Phanramphoei N Frantz, Aleksandr Barinov, Claude Ruffié, et al.
Ebiomedicine
|
July 17, 2022
Splenic clearance of rigid erythrocytes as an inherited mechanism for splenomegaly and natural resistance to malaria
Benoît Henry, Geoffroy Volle, Hilaire Akpovi, et al.
Open Forum Infectious Diseases
|
March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Cynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
Nature Communications
|
January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
Nature Communications
|
May 14, 2021
Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)
Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
The Lancet. Infectious Diseases
|
February 15, 2014
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial
Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, et al.
Page
of 14